Advances in graft-versus-host disease biology and therapy

Research output: Contribution to journalArticle

454 Citations (Scopus)

Abstract

Allogeneic haematopoietic stem cell transplantation is used to treat a variety of disorders, but its efficacy is limited by the occurrence of graft-versus-host disease (GVHD). The past decade has brought impressive advances in our understanding of the role of stimulatory and suppressive elements of the adaptive and innate immune systems from both the donor and the host in GVHD pathogenesis. New insights from basic immunology, preclinical models and clinical studies have led to novel approaches for prevention and treatment. This Review highlights the recent advances in understanding the pathophysiology of GVHD and its treatment, with a focus on manipulations of the immune system that are amenable to clinical application.

Original languageEnglish (US)
Pages (from-to)443-458
Number of pages16
JournalNature Reviews Immunology
Volume12
Issue number6
DOIs
StatePublished - Jun 2012

Fingerprint

Graft vs Host Disease
Immune System
Hematopoietic Stem Cell Transplantation
Allergy and Immunology
Therapeutics

ASJC Scopus subject areas

  • Immunology

Cite this

Advances in graft-versus-host disease biology and therapy. / Blazar, Bruce R.; Murphy, William J; Abedi, Mehrdad.

In: Nature Reviews Immunology, Vol. 12, No. 6, 06.2012, p. 443-458.

Research output: Contribution to journalArticle

@article{b9829884c11244eb84e8dfbd3a2d7e56,
title = "Advances in graft-versus-host disease biology and therapy",
abstract = "Allogeneic haematopoietic stem cell transplantation is used to treat a variety of disorders, but its efficacy is limited by the occurrence of graft-versus-host disease (GVHD). The past decade has brought impressive advances in our understanding of the role of stimulatory and suppressive elements of the adaptive and innate immune systems from both the donor and the host in GVHD pathogenesis. New insights from basic immunology, preclinical models and clinical studies have led to novel approaches for prevention and treatment. This Review highlights the recent advances in understanding the pathophysiology of GVHD and its treatment, with a focus on manipulations of the immune system that are amenable to clinical application.",
author = "Blazar, {Bruce R.} and Murphy, {William J} and Mehrdad Abedi",
year = "2012",
month = "6",
doi = "10.1038/nri3212",
language = "English (US)",
volume = "12",
pages = "443--458",
journal = "Nature Reviews Immunology",
issn = "1474-1733",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Advances in graft-versus-host disease biology and therapy

AU - Blazar, Bruce R.

AU - Murphy, William J

AU - Abedi, Mehrdad

PY - 2012/6

Y1 - 2012/6

N2 - Allogeneic haematopoietic stem cell transplantation is used to treat a variety of disorders, but its efficacy is limited by the occurrence of graft-versus-host disease (GVHD). The past decade has brought impressive advances in our understanding of the role of stimulatory and suppressive elements of the adaptive and innate immune systems from both the donor and the host in GVHD pathogenesis. New insights from basic immunology, preclinical models and clinical studies have led to novel approaches for prevention and treatment. This Review highlights the recent advances in understanding the pathophysiology of GVHD and its treatment, with a focus on manipulations of the immune system that are amenable to clinical application.

AB - Allogeneic haematopoietic stem cell transplantation is used to treat a variety of disorders, but its efficacy is limited by the occurrence of graft-versus-host disease (GVHD). The past decade has brought impressive advances in our understanding of the role of stimulatory and suppressive elements of the adaptive and innate immune systems from both the donor and the host in GVHD pathogenesis. New insights from basic immunology, preclinical models and clinical studies have led to novel approaches for prevention and treatment. This Review highlights the recent advances in understanding the pathophysiology of GVHD and its treatment, with a focus on manipulations of the immune system that are amenable to clinical application.

UR - http://www.scopus.com/inward/record.url?scp=84861576998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861576998&partnerID=8YFLogxK

U2 - 10.1038/nri3212

DO - 10.1038/nri3212

M3 - Article

C2 - 22576252

AN - SCOPUS:84861576998

VL - 12

SP - 443

EP - 458

JO - Nature Reviews Immunology

JF - Nature Reviews Immunology

SN - 1474-1733

IS - 6

ER -